Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-17

FDA Approved: DIFLUPREDNATE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved an original application for difluprednate ophthalmic (generic) manufactured by Amneal Pharmaceuticals NY LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Difluprednate ophthalmic (Difluprednate)

Snippet

ORIG AP for DIFLUPREDNATE (DIFLUPREDNATE OPHTHALMIC)